The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Open accessPublished version of a preprint
Abstract
Recent studies have identified a unique cancer-associated fibroblast (CAF) population termed antigen-presenting CAFs (apCAFs), characterized by the expression of major histocompatibility complex class II molecules, suggesting a function in regulating tumor immunity. Here, by integrating multiple single-cell RNA-sequencing studies and performing robust lineage-tracing assays, we find that apCAFs are derived from mesothelial cells. During pancreatic cancer progression, mesothelial cells form apCAFs by downregulating mesothelial features and gaining fibroblastic features, a process induced by interleukin-1 and transforming growth factor β. apCAFs directly ligate and induce naive CD4 + T cells into regulatory T cells (Tregs) in an antigen-specific manner. Moreover, treatment with an antibody targeting the mesothelial cell marker mesothelin can effectively inhibit mesothelial cell to apCAF transition and Treg formation induced by apCAFs. Taken together, our study elucidates how mesothelial cells may contribute to immune evasion in pancreatic cancer and provides insight on strategies to enhance cancer immune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lineage tracing analysis of perivascular fibroblasts, expressing the transcription factor Gli1, showed this population expands to form nearly half of pre-CAFs in PanINs and CAFs in cancer”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
In the citing paper
“parenchymal fibroblasts, expressing Hoxb6 do not expand during carcinogenesis144”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Reversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 540
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)
Benešová, I., Kalkusova, K., Kwon, Y., Táborská, P., Stakheev, D., Krausová, K., Smetanová, J., Ozaniak, A., Bartůňková, J., Smrž, D., et al. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5785 · Cited by 3
Wilms Tumor 1–Expressing Stromal Cells Promote Pancreatic Cancer Progression
Bischoff, A. C., Brown, K. L., Lasse-Opsahl, E., Watkoske, H. R., Espinoza, C. E., Okoye, J., Olivei, A., Green, L. M., Rai, R., The, S., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1014
Self-citationLi, Y., Di, X., Chen, J., Wei, J., Li, T., Wang, K., Liao, B., & Luo, D. (2025) · MedComm – Oncology · doi:10.1002/mog2.70048 · Cited by 2
Sahoo, S., Kashyap, A., Muduly, D. K., & Sahoo, S. K. (2026) · Phytotherapy Research · doi:10.1002/ptr.70194 · Cited by 2
Zu, P., & Yu, Z. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1761070 · Cited by 2
Nakamura, D., Nishio, T., Oguma, Y., Taura, K., Koyama, Y., Zhan, M., Kurata, Y., Okura, K., Yoh, T., Nishino, H., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000930 · Cited by 2
Xu, J., Chu, T., Liu, Z., (281351), H. L., Duan, K., Liu, X., Yang, H., Lou, F., Liu, H., Chi, Y., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102275 · Cited by 2
Foxs1-mediated transformation of CD34+ fibroblast to myCAFs promotes tumor growth
Yang, J., Chen, T., Zhang, R., Xu, J., Zhao, X., Yang, M., Chen, Z., Sun, S., Chen, X., Zhang, S., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00476-8 · Cited by 2
Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies
Yousefi, M., Farahpour, M. R., Alizadeh, N., Abedian, A., & Baradaran, B. (2026) · Discover Oncology · doi:10.1007/s12672-026-05518-8 · Cited by 2
Nagler, A., Sud, A., Ghannam, J. Y., Pomerance, L., Robles-Oteíza, C., Afeyan, A. B., Weir, J. A., Russell, A. J. C., Lu, W. S., Orden, M. V., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03194-1 · Cited by 2
Ringham, O. R., Rivera, M., Loffredo, L. F., Ozsoy, M. A., Healy, C. M., Cheng, M. F., Jin, Y., Chen, N., Santos, K. D. L., Azizi, E., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02607-2 · Cited by 2
Wahbi, W., Awad, S. A., Salo, T. A., & Al‐Samadi, A. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113911 · Cited by 2
The necessary role of an efficient tumor immunotherapy by MHC II expression on amateur APCs
Zhong, J., Lin, X., & Hu, H. (2024) · Malignancy Spectrum · doi:10.1002/msp2.29 · Cited by 2
Shaping the microenvironment in peritoneal metastases
Ren, Q., & Vermeulen, L. (2025) · Nature Cancer · doi:10.1038/s43018-024-00878-y · Cited by 3
Road Map to Defeat Pancreatic Cancer
Ferguson, L. P., & Tuveson, D. A. (2025) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060624-044323 · Cited by 2
Current Organoid Culture Systems in Pancreatic Cancer
Liu, L., Sun, J., Chen, S., Tang, X., Zhang, S., Wang, M., Yue, Q., Zhong, C., & Li, L. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266392238250423115420 · Cited by 2
Chauvin, M. Y., Tromelin, E., Roche-Prellezo, J., Lancia, H. H., Meinsohn, M.-C., Coletti, C. M., Nguyen, N. M., Lafont, V., Michaud, H., Mishra, R. K., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03425-4 · Cited by 4
Guinn, S. R., Perez, B., Tandurella, J. A., Ramani, M., Lee, J. W., Zabransky, D. J., Kartalia, E., Patel, J. G., Zlomke, H., Nicolson, N. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.07.631784 · Cited by 2
Wu, S., Amin, S., Lee, C., Richard, J.-B., Merali, N., Morrell, C., Overend, L., Gao, W., Tucci, F., Gordon-Weeks, A. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.662328 · Cited by 2
Yan, J., Liu, Q., Xiao, G., Du, J., Yang, C., Liu, C., Lin, S., Bai, Z., Liu, C., Huang, J., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2023.11.022 · Cited by 1
Chen, X., Li, Y., Huang, J., Zhang, Q., Tan, C., Liu, Y., & Du, Z. (2024) · Discover Oncology · doi:10.1007/s12672-024-01505-z · Cited by 1
Watabe, S., Kikuchi, Y., Komura, D., Watanabe, M., Kato, M., & Uozaki, H. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04153-y · Cited by 1
O’Byrne, A. M., Grasso, C., de Winde, C. M., Mikula, A. M., de Graça, C. G., Semmelink, J. F., Remmerswaal, E. B. M., Bolt, J. W., van de Sande, M. G. H., Mebius, R. E., et al. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxaf042 · Cited by 1
Zhou, F., Yang, K., Wang, H., Han, M., Zhang, D., Wang, J., Wang, H., Wang, Y., Gong, F., Zheng, H., et al. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.201021 · Cited by 1
Singh, R., Yousefian, N., Allen, W. M., Silva, A. D., Anaraki, C., Michels, A. K., Calderon, S. E., Loveless, I. M., Rastelli, D., George, A., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101872 · Cited by 1
Wang, Y., Gong, X., Chen, H., Niu, P., Liu, Z., & Sun, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.170069 · Cited by 1
Kehrberg, R. J., Bhyravbhatla, N., Alsafwani, Z. W., Li, X., Natarajan, G., Khan, I. K., Brand, R. E., Jain, M., Batra, S. K., & Sushil Kumar, K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00926.2024 · Cited by 1
Emerging role of the adaptive immunity in aortic aneurysm and dissection
Hu, Y., Wang, M., & Zhang, Z. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107558 · Cited by 1
Enhanced MHC Class‐II Expression in Fibroblastic Reticular Cells Associates with Maturation
Roet, J. E. G., de Graça, C. G., de Kok, M., Panocha, D., Konijn, T., Roest, H. P., van der Laan, L. J. W., van Baarsen, L. G. M., de Winde, C. M., & Mebius, R. E. (2025) · European Journal of Immunology · doi:10.1002/eji.70086 · Cited by 1
Frank, M., Ghirardello, G., Howie, J. M., Braun, N., Zirnbauer, R., Stecher, C., Gruener, S., Regele, H. M., Barozzi, I., Bergmann, M. M., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218228 · Cited by 2
Han, L., Zhang, Q., Wu, Y., Luo, W., Mo, S., Fang, H., Li, Q., Wang, R., Cai, G., & Dai, W. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025148 · Cited by 1
ApCAFs: spatial niches and therapeutic insights across cancers
Li, W., Nsubuga, G., & Biffi, G. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.12.005 · Cited by 1
Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection
Dam, N., Ioannidis, G., Hawinkels, L. J. A. C., & Kemp, V. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2617274 · Cited by 1
Xing, B., Shen, X., Jia, X., Zhang, Y., Liu, Z., Guo, X., Li, X., & Liu, Z. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020184 · Cited by 1
Self-citationKang, K., Li, X., Wang, S., Huang, C., & Wu, Z. (2026) · Inflammation · doi:10.1007/s10753-025-02387-1 · Cited by 1
Tumorigenesis and Tumor Microenvironment in Lung Cancer
Dhillon, P., Carroll, M., & Cheng, H. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48030247 · Cited by 2
Sakane, S., Nishio, T., Fuji, H., Park, S. Y., Ishizuka, K., Miciano, C., Kimura, Y., Hosseini, M., Diggle, K., Zhang, V., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101785 · Cited by 1
Dynamic responses of cancer-associated fibroblasts to therapy in primary liver cancer
Ruan, Q., Tan, Y. R., Kim, M., Li, D., Bridle, K. R., O’Rourke, T., Crawford, D. H., & Liang, X. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218566 · Cited by 2
Tang, Y., Luo, X., Zhou, F., Gu, J., Li, X. F., Yang, G., Zhang, T. P., & You, L. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189604 · Cited by 1
Harada, Y., Masuda, A., Matsuura, T., Nagata, K., Nanno, Y., Masamune, A., Kodama, Y., Hara, E., & Matsumoto, T. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101808 · Cited by 1
Truong, H. T. T., Kwon, W., Woo, H. J., Kim, M. S., Trần, N. Q., & Joung, J. Y. (2026) · Cancers · doi:10.3390/cancers18101600 · Cited by 1
Reprogramming Cancer-associated Fibroblast: the Emerging Role of Traditional Chinese Medicine
Zhang, T., Zhang, Q.-C., Liu, S.-J., Zhou, L.-S., Cheng, H.-B., Sun, D.-D., & Sun, Y. (2026) · Cancer Bioscience · doi:10.1016/j.cbs.2026.100003 · Cited by 1
The role of cancer-associated fibroblasts in various cancer drug resistance
Dang, F., Na, J., Xiao, L., Tian, X., Shao, J., Zhong, L., & Zhao, Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218584 · Cited by 1
Wang, J., Qian, J., Yang, X., Huang, C., Wei, T., Zhou, J., Zhong, G., Zh, Z., & Zhang, Y. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03735-1 · Cited by 3
Self-citationWu, W., & Wei, Z. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05609-x · Cited by 1
Yang, X., Steffani, M., Nadella, S., Sheppard, D., Rieder, F., Rinkevich, Y., Kramann, R., Tuveson, D. A., & Schwabe, R. F. (2026) · JCI Insight · doi:10.1172/jci.insight.202529 · Cited by 1
Catalytic profiling of extracellular vesicles maps altered cancer metabolism
Chen, Q., Zhang, Y., Natalia, A., Zhou, J., Yu, Z., Ding, X., Ong, C. J., So, J. B. Y., & Shao, H. (2026) · Nature Nanotechnology · doi:10.1038/s41565-026-02230-0 · Cited by 1
Self-citationMirzabeigi, Y., Youssef, J., Gonzalez, J. S., Martinez, T., Avellan, R., Wong, A. G., Perez, M., Carvajal, L. L., Abou-Kheir, W. G., & Bahmad, H. F. (2026) · Cancers · doi:10.3390/cancers18142358 · Cited by 1
Precision targeting of stromal states in pancreatic cancer: a clinical perspective
Wolters, A., Bijlsma, M. F., & Prakash, J. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.07.003 · Cited by 1
Li, W., Jihad, M., Lloyd, E. G., Zaccaria, M., Mucciolo, G., Nsubuga, G., Koonan-Lonappan, A., Henríquez, J. A., Cheng, P. S. W., Harish, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02057-w · Cited by 1
Vitamin D and pancreatic cancer
de Maturana, E. L., Zagorac, S., Malats, N., & Real, F. X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00042-2 · Cited by 1
Zheng, X. M., Zhang, X., Yu, J., & Zheng, J. (2025) · Gene · doi:10.1016/j.gene.2025.149439 · Cited by 1
Yang, L., Duan, Y., Yu, J. G., Deng, D., Ma, L., Yu, R., Song, W., Yu, J., Lan, C., & Yi, P. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00092 · Cited by 1
Bibliometric analysis of global research trends in pancreatic cancer immunotherapy
Fu, T., Chen, Y., Wang, H., He, L., Zhang, J., Zhou, Y., Duan, X., & Zhang, X. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2538330 · Cited by 1
Luo, Y., Deng, F., Zhang, Y., & Xiao, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1014565 · Cited by 1
Self-citationLung CAFs Show T Cells the Velvet Rope
Sherman, M. H. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0944 · Cited by 1
Obacz, J., Nibhani, R., Adams, T. S., Schupp, J. C., Valer, J. A., Veale, N., Aresu, G., Coonar, A. S., Peryt, A., Biffi, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.03.518966 · Cited by 1
Varveri, A., Papadopoulou, M., Papadovasilakis, Z., Compeer, E. B., Legaki, A., Delis, A. D., Damaskou, V., Boon, L., Papadogiorgaki, S., Samiotaki, M. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.572969 · Cited by 1
Single-cell and spatial atlas of steatotic liver disease-related hepatocellular carcinomaPreprint
Prawira, A., Xu, H., Leow, W. Q., Otsuka, M., Chen, Z., Rahbari, M., Hazirah, S. N., Wasser, M., Chung, A. Y. F., Goh, B. K. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.09.593073 · Cited by 1
Vasudev, A., Moore, C. R., Calindi, A., Kang, S., Helm, B. R., Srinivasan, J., Shah, S., Zong, R., Singarapu, N., Casey, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.04.641047 · Cited by 1
ecDNA-driven oncogene super-expressors shape immunoevasive tumor microenvironmentPreprint
Qiao, K., Yang, Q., Li, T., Chen, X., Yazgan, Z., Kim, Y. J., Gilbreath, C., Lim, J. Y. S., Xie, Y., Sun, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.15.688565 · Cited by 1
Self-citationBandi, D. S. R., Sarvesh, S., Nagaraju, G. P., Kim, H., Foote, J. B., Bae, S., Yoon, K. J., Malla, M., Masood, A., Akce, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.15.699725 · Cited by 1
Tracing back to one of the origins of immune evasion in pancreatic cancer
Henríquez, J. A., & Biffi, G. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.002
Immunotherapy in Pancreatic Cancer
Yeung, Z. P., & Kundranda, M. N. (2023) · Springer eBooks · doi:10.1007/978-3-031-38623-7_6
Xi, X., Chen, Y., Deng, T., Zhu, J., Zhao, Y., Liu, S., Qiu, K., Ke, Y., Li, G., Zhu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3874261/v1
Li, X., Gao, Z., Yang, M., Yang, C., Yang, D., Cui, W., Wu, D., & Zhou, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3952364/v1
Components of the microenvironment of soft tissue sarcomas. Part I
Lokhonina, А. V., Jumaniyazova, E. D., Dzhalilova, D. S., Kosyreva, A. M., Казарян, Г. Г., & Fatkhudinov, T. (2024) · Bone and soft tissue sarcomas tumors of the skin · doi:10.17650/2219-4614-2024-16-1-25-33
Comparison of Different Approaches to Single Cell RNA Sequencing of Cancer Associated FibroblastsPreprint
Kung, H., Loycano, M., Zheng, L., Chen, S. Y., & Zimmerman, J. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591011
Yang, J., Lin, Q., Liu, X., Chen, K., Chen, X., Han, J., & Liao, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4335610/v1
Su, X., Guo, Y., & Li, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-60370-8
Jenkins, B. H., Tracy, I., Rodrigues, M. F. S., Smith, M. J., Martinez, B. R., Edmond, M., Mahadevan, S. K., Rao, A. S., Zong, H., Liu, K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5125055/v1
The Bladder Tumor Microenvironment
Gao, H., Nikolos, F., Satkunasivam, R., & Chan, K. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68505-7_12
Gong, W., Wu, Z., Luo, B., Kong, D., Miao, X., Liu, H., Xie, W., Hu, C., He, J., Cao, D., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5850890/v1
Zhou, Z., Ferlita, A. L., Palavalli, M. H., Chen, X., Tyler, L. A., Ejaz, A. M., Beane, J. D., Polanco, P. M., Huang, H., & Kim, A. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.11.648429
Self-citationPancreatic Cancer Immunotherapy: A Team-Based Approach
Patel, K., Lee, P. P., Weng, J. K., Melstrom, L. G., Raoof, M., Lewis, A., & Chung, V. M. (2025) · Cancer treatment and research · doi:10.1007/978-3-031-97242-3_11
Roger, É., Mummey, H. M., Zimmer, E., Srinivasan, D., Härle, A., Moubri, L., Beutel, A. K., Singh, R., Ekizce, M., Melzer, M. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676458
Chen, C., Gribbin, K. P., Li, X., Ozmen, T. Y., Ozmen, F., Sivagnanam, S., Kim, J., Blise, K. E., Yang, X., Zhang, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.21.683745
Self-citationZhou, Y. D., Wang, Z. P., Schaffer, E., Komnick, M. R., Brown, H. M., Taylor, G. M., Fiske, K. L., Sheehan, C. S., Dermody, T. S., Muir, A., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5930562
Self-citationIGFBPs define distinct pro-tumorigenic CAF subtypes in lung cancer tumour-microenvironmentPreprint
Yengkhom, G., Nandgaonkar, K. K., Ramanathan, S., Schlegel, J. A., Dong, M., Thorat, R. A., Kumar, R., Yadav, S. C., Prabhash, K., & Arandkar, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692056
Li, W., Jihad, M., Lloyd, E. G., Mucciolo, G., Henríquez, J. A., Zaccaria, M., Cheng, P. S. W., Harish, S., Mills, S., Johnson, P. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.05.692494
Kim, S., Leem, G., Choi, J., Koh, Y., Lee, S., Nam, S.-H., Kim, J. S., Park, C. H., Hwang, H. K., Min, K. I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25123881
Waki, Y., Morine, Y., Noma, T., Takasu, C., Teraoku, H., Yamada, S., Saito, Y., Ikemoto, T., & Shimada, M. (2023) · Figshare · doi:10.6084/m9.figshare.24655835
Kim, S., Leem, G., Choi, J., Koh, Y., Lee, S., Nam, S.-H., Kim, J. S., Park, C. H., Hwang, H. K., Min, K. I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675240
Kim, S., Leem, G., Choi, J., Koh, Y., Lee, S., Nam, S.-H., Kim, J. S., Park, C. H., Hwang, H. K., Min, K. I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25124095
Sun, Y., Ying, K., Sun, J., Wang, Y., Qiu, L., Ji, M., Sun, L., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26308973
Varinelli, L., Battistessa, D., Guagliò, M., Zanutto, S., Illescas, O., Lorenc, E., Pisati, F., D, S. K. M., Cattaneo, L., Sabella, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25744371
Yuntao, Y. A. N. G., Zhang, Y., Shen, Z., Chen, S., Zhang, Y., & Wang, X. (2026) · Open Medicine · doi:10.1515/med-2025-1323 · Cited by 1
Self-citationTransforming role of cancer associated fibroblasts: From therapeutic barriers to promising targets
Chang, J., Yu, X., Xiong, N., Zhu, M., Yang, C., Zhao, Wang, C., Wang, S., Ye, Y., & Shen, Z. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105143
CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell FunctionPreprint
Chabu, C. Y., Kazmierczak, R. A., Hasani, M., Patterson, N., Wang, Q., Canti, L., Tesfay, M. Z., Cios, A., Dhagat-Mehta, B., Pastor, M. Q., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701790
Zhang, Y., Lin, J., Liu, N., Chen, W., Zhang, L., Yuan, H., & Chen, Y. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02044-7 · Cited by 1
Self-citationZhou, Z., Ferlita, A. L., Palavalli, M. H., Chen, X., Tyler, L. A., Ejaz, A. M., Beane, J. D., Polanco, P. M., Huang, H., & Kim, A. C. (2026) · Oncogene · doi:10.1038/s41388-026-03743-7
Self-citationRole of the stromal microenvironment in PDAC and resistance to therapies
Ode, A. (2024) · theses.fr (ABES) · doi:10.70675/0452e0e9z98e8z47d9za007zd4b472926aab
Cancer associated fibroblasts stimulate cancer resistance to therapy
Zajac, O. (2024) · theses.fr (ABES) · doi:10.70675/62ded90az3604z4c61zb521z8878a12ed0d9
Yu, Y.-N., Jin, S.-Q., Lu, Y.-T., & Han, L.-Z. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i4.117197
Zhou, Y. D., Wang, P., Schaffer, E., Komnick, M. R., Brown, H. M., Taylor, G. M., Fiske, K. L., Sheehan, C., Dermody, T. S., Muir, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117324
The resilient subset: cancer stem cells at the core of immunotherapy resistance
Gajón, J. A., Esperante, D., Ko, N., Jimenez-Miranda, A., Muñoz-Cruz, S., Fuentes‐Pananá, E. M., & Bonifaz, L. C. (2025) · Immunotherapy Advances · doi:10.1093/immadv/ltag006
From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal
Ye, P., 匡洪宇, Lin, A., Tang, B., Wang, Q., Zhang, H., Wong, H. Z. H., Zhang, J., Cheng, Q., Glaviano, A., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02669-8
Qin, Z., Ma, J., Jü, R., & Guo, L. (2026) · Organ medicine. · doi:10.1002/orm2.70044
Shah, N., Quaye, M. B., Sudula, B., Kulkarni, N., Upreti, A., Malkoochi, A., Aileni, T. R., Karambelkar, K., Peterson, A., Mahmoud, D., et al. (2026) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-026-00909-w
Self-citationEmerging concepts, hot topics, and open questions in today’s pancreatic cancer research
Keber, C. U., Schmitt, M., Visekruna, A., Brichkina, A. I., von Strandmann, E. P., Bartsch, J. W., Huber, M., Bauer, U., Gress, T. M., & Lauth, M. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189614
Metadata
- Authors
- Huang, H., Wang, Z., Zhang, Y., Pradhan, R. N., Ganguly, D., Chandra, R., Murimwa, G., Wright, S., Gu, X., Maddipati, R., Müller, S., Turley, S. J., & Brekken, R. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of California San Diego (US)
- Genentech (US)
- Corresponding author
- Huang, Huocong
- Brekken, Rolf A.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 40
- Issue
- 6
- Pages
- 656-673.e7
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC9197998
- OpenAlex
- W4229052987
- Cited by
- 542
- References
- 62
- Citations by year
- 2026: 112 · 2025: 158 · 2024: 144 · 2023: 80 · 2022: 41
- FWCI
- 44.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA210181, CA243577, CA252009)
- Burroughs Wellcome Fund
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- mesothelial cells, regulatory T cells, pancreatic cancer, tumor immune evasion, mesothelin, interleukin-1, TGF-beta, MHC class II, CD4+ T cell tolerance, lineage tracing, cancer immunotherapy
- MeSH terms
- Cancer-Associated Fibroblasts, Fibroblasts, Humans, Pancreatic Neoplasms, Transforming Growth Factor beta, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review